Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole plus cefazolin prophylaxis for surgical site infection prevention in hysterectomy and ovarian surgery
IRCT20120623010089N5Phase 3Recruiting
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jul 2025
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of metronidazole and cefazolin in surgical site infection (SSI) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Length of hospital stay and Patient-reported symptoms or documented infection after surgery. Started Jul 2025; status: recruiting.
02
Drugs
metronidazolecefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20120623010089N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120623010089N5.